BSE Live
Dec 31, 13:57Prev. Close
388.45
Open Price
388.75
Bid Price (Qty.)
381.50 (16)
Offer Price (Qty.)
382.25 (230)
NSE Live
Dec 31, 13:57Prev. Close
386.55
Open Price
388.00
Bid Price (Qty.)
381.75 (699)
Offer Price (Qty.)
381.95 (150)
| Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 6.68 | 6.68 | 6.68 | 6.58 | 5.72 | |
| Total Share Capital | 6.68 | 6.68 | 6.68 | 6.58 | 96.15 | |
| Reserves and Surplus | 695.72 | 600.48 | 689.43 | 529.64 | 149.54 | |
| Total Reserves and Surplus | 695.72 | 600.48 | 689.43 | 529.64 | 149.54 | |
| Total Shareholders Funds | 702.41 | 607.15 | 696.11 | 536.22 | 245.69 | |
| Minority Interest | 4.83 | 2.90 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 493.27 | 550.83 | 372.92 | 212.91 | 484.20 | |
| Deferred Tax Liabilities [Net] | 85.00 | 82.03 | 63.90 | 46.61 | 29.65 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 578.27 | 632.86 | 436.82 | 259.51 | 513.86 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 212.17 | 152.18 | 25.68 | 0.06 | 102.02 | |
| Trade Payables | 147.50 | 162.42 | 109.67 | 125.12 | 87.96 | |
| Other Current Liabilities | 5.74 | 6.83 | 18.12 | 16.91 | 15.05 | |
| Short Term Provisions | 48.85 | 186.11 | 17.84 | 14.12 | 50.90 | |
| Total Current Liabilities | 414.25 | 507.54 | 171.30 | 156.20 | 255.93 | |
| Total Capital And Liabilities | 1,699.77 | 1,750.45 | 1,304.23 | 951.93 | 1,015.48 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 662.22 | 656.17 | 413.53 | 262.51 | 126.61 | |
| Intangible Assets | 29.21 | 25.08 | 36.81 | 32.41 | 12.84 | |
| Capital Work-In-Progress | 171.96 | 177.70 | 222.17 | 132.62 | 96.71 | |
| Fixed Assets | 863.39 | 858.96 | 672.51 | 427.54 | 236.16 | |
| Non-Current Investments | 72.67 | 70.06 | 15.27 | 0.01 | 0.01 | |
| Deferred Tax Assets [Net] | 13.99 | 48.55 | 4.35 | 8.33 | 4.98 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.20 | 0.42 | 0.55 | 0.70 | 0.96 | |
| Total Non-Current Assets | 950.25 | 977.98 | 692.67 | 436.58 | 242.12 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 457.67 | 451.30 | 214.58 | 209.19 | 181.71 | |
| Trade Receivables | 107.59 | 120.17 | 145.88 | 91.62 | 76.68 | |
| Cash And Cash Equivalents | 47.04 | 74.84 | 154.68 | 165.67 | 444.90 | |
| Short Term Loans And Advances | 137.20 | 126.15 | 96.41 | 48.87 | 70.06 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 749.51 | 772.47 | 611.55 | 515.35 | 773.36 | |
| Total Assets | 1,699.77 | 1,750.45 | 1,304.23 | 951.93 | 1,015.48 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 33.01 | 59.49 | 41.51 | 14.21 | 92.45 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 24.35 | 46.61 | 0.02 | 0.01 | 0.01 | |
| Non-Current Investments Unquoted Book Value | 14.38 | 5.07 | 15.26 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y